Therapeutic indications

They are relaxing medicines used as a symptom reliever by reducing bronchoconstriction in asthma. They should not be used as a controlling drug.

4.2. Posology and application form

Posology / application frequency and duration:

VENTOLIN’s effect in many patients is 4-6 hours.

Increased beta2 agonist use may be a sign of asthma worsening. In this case, the treatment plan of the patient may need to be reassessed and glucocorticosteroid therapy should be considered.

As side effects can be seen with overdose, dosage or administration frequency can only be increased by doctor advice.

In relieving acute bronchospasm:

Adults: 100 or 200 micrograms.

Prevention of allergy or exercise-induced bronchospasm:

Adults: 200 micrograms of exposure to the alejene or 10-15 minutes before exercise

The use of VENTOLIN as needed should not exceed 4 times a day. As such, the need for continuous use or a sudden increase in the dose indicates a worsening of asthma (see Special Precautions for Use and Special Precautions for Use).

VENTOLIN can be used as a preventive measure to relieve the symptoms of inhalers when they occur, in conditions known to the patient, such as conditions that can lead to asthma attack (eg exercise, inevitable alejene exposure).

Method of Application:

VENTOLIN inhaler is only used by inhalation.

Patients suffering from coordination difficulty when using pressure-gauge dose inhalers can apply VENTOLIN with a Volumatic ™ spacer.

Additional information on special populations:

Kidney / Liver failure:

There is no data.

Pediatric population:

For children between 2-12 years: 100 micrograms, 200 micrograms of the dose can be taken if necessary.

12 years and over in children: Adult is applied to the desire.

Prevention of allergy or exercise-induced bronchospasm:

In children between 2 and 12 years old: 100 μg before exposure to alejene or exercise, 200 μg of the dose can be removed when necessary.

12 years and over in children: Adult is applied to the desire.

For additional information on use in children under 4 years of age refer to “5.1. Pharmacodynamic Properties “section.

Children under the age of 5 may use a Volumatic ™ spacer device or a Babyhaler ™ spacer device with a face mask to facilitate application.

Geriatric population:

4.3. contraindications

VENTOLIN is contraindicated in patients with a history of hypersensitivity to any of the ingredients (see List of Auxiliary Items).

4.4. Special use warnings and precautions

A stepwise treatment program should be followed in the treatment of asthma and the response of the patient should be monitored clinically and with lung function tests.

The increase in the use of short-acting beta2 agonists to control symptoms is indicative of worsening of asthma control. In this case, the treatment plan of the patient should be re-evaluated.

Sudden and progressive deterioration in asthma control is potentially life-threatening and should be considered for starting corticosteroid therapy or increasing the dose. Patients at risk can begin daily peak flow controls.

Patients should be advised not to increase the frequency of dosing or administration, but to seek medical attention if the relief they provide from the medication is diminished or the duration of the usual effect is shortened.